Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Gold nanorods: from anisotropy to opportunity. An evolution update.

Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I.

Nanomedicine (Lond). 2019 May 10. doi: 10.2217/nnm-2018-0409. [Epub ahead of print]

PMID:
31075049
2.

The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis.

Braicu C, Zimta AA, Harangus A, Iurca I, Irimie A, Coza O, Berindan-Neagoe I.

Cancers (Basel). 2019 Apr 30;11(5). pii: E605. doi: 10.3390/cancers11050605. Review.

3.

Transient leukemia of Down Syndrome.

Sas V, Blag C, Zaharie G, Puscas E, Lisencu C, Andronic-Gorcea N, Pasca S, Petrushev B, Chis I, Marian M, Dima D, Teodorescu P, Iluta S, Zdrenghea M, Berindan-Neagoe I, Popa G, Man S, Colita A, Stefan C, Kojima S, Tomuleasa C.

Crit Rev Clin Lab Sci. 2019 May 1:1-37. doi: 10.1080/10408363.2019.1613629. [Epub ahead of print]

PMID:
31043105
4.

Curcumin: Total-Scale Analysis of the Scientific Literature.

Yeung AWK, Horbańczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan RY, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Šmejkal K, Atanasov AG.

Molecules. 2019 Apr 9;24(7). pii: E1393. doi: 10.3390/molecules24071393.

5.

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies.

Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, Pop L, Raduly L, Barbat A, Moldovan A, Moldovan C, Tigu AB, Ionescu C, Atanasov AG, Irimie A, Berindan-Neagoe I.

Int J Mol Sci. 2019 Mar 9;20(5). pii: E1199. doi: 10.3390/ijms20051199.

6.

Novel therapeutic strategies for stroke: The role of autophagy.

Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S.

Crit Rev Clin Lab Sci. 2019 May;56(3):182-199. doi: 10.1080/10408363.2019.1575333. Epub 2019 Mar 1.

PMID:
30821184
7.

Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance.

Braicu C, Zimta AA, Gulei D, Olariu A, Berindan-Neagoe I.

Cell Mol Life Sci. 2019 Apr;76(8):1559-1577. doi: 10.1007/s00018-019-03016-5. Epub 2019 Feb 25. Review.

PMID:
30805658
8.

The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry.

Zimta AA, Baru O, Badea M, Buduru SD, Berindan-Neagoe I.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E406. doi: 10.3390/ijms20020406. Review.

9.

Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.

Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S.

Pharmacol Res. 2019 Mar;141:466-480. doi: 10.1016/j.phrs.2019.01.014. Epub 2019 Jan 11. Review.

PMID:
30639373
10.

CRISPR-based RNA editing: diagnostic applications and therapeutic options.

Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242. Epub 2019 Jan 21. No abstract available.

PMID:
30632384
11.

The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes.

Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I.

Cells. 2019 Jan 8;8(1). pii: E29. doi: 10.3390/cells8010029. Review.

12.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

13.

Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells.

Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R.

Cancer Manag Res. 2018 Nov 15;10:5709-5724. doi: 10.2147/CMAR.S163328. eCollection 2018. Erratum in: Cancer Manag Res. 2019 Jan 15;11:691.

14.

Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient.

Zaharie F, Pop LA, Petrushev B, Jurj A, Muresan MS, Eniu D, Fetica B, Petkov B, Pasca S, Piciu D, Rus I, Deak D, Dima D, Desmirean MS, Tomuleasa C, Berindan-Neagoe I.

Histol Histopathol. 2018 Nov 23:18067. doi: 10.14670/HH-18-067. [Epub ahead of print]

PMID:
30467824
15.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2.

16.

Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.

Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho YS.

Crit Rev Oncog. 2018;23(5-6):347-370. doi: 10.1615/CritRevOncog.2018027566.

PMID:
30311565
17.

Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.

Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I.

Leuk Lymphoma. 2019 Apr;60(4):876-885. doi: 10.1080/10428194.2018.1516881. Epub 2018 Oct 2.

PMID:
30277128
18.

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.

Temian DC, Pop LA, Irimie AI, Berindan-Neagoe I.

J Breast Cancer. 2018 Sep;21(3):233-243. doi: 10.4048/jbc.2018.21.e41. Epub 2018 Sep 20. Review.

19.

Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools.

Gulei D, Petrut B, Tigu AB, Onaciu A, Fischer-Fodor E, Atanasov AG, Ionescu C, Berindan-Neagoe I.

Crit Rev Biochem Mol Biol. 2018 Oct;53(5):564-577. doi: 10.1080/10409238.2018.1508276. Epub 2018 Sep 24. Review.

PMID:
30247075
20.

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.

Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I.

Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Review.

PMID:
30238808

Supplemental Content

Loading ...
Support Center